Is OPKO Health (NASDAQ:OPK) Using Too Much Debt?
Is OPKO Health (OPK) the Best NASDAQ Penny Stock to Buy Right Now?
Analysts Offer Insights on Healthcare Companies: Myomo (MYO), Ionis Pharmaceuticals (IONS) and Opko Health (OPK)
Piper Sandler Maintains Opko Health(OPK.US) With Buy Rating, Maintains Target Price $3
OPKO Health (NASDAQ:OPK Shareholders Incur Further Losses as Stock Declines 4.9% This Week, Taking Three-year Losses to 60%
OPKO Health to Participate in the Piper Sandler 36th Annual Healthcare Conference
Express News | NextPlat Reports $49.8 Million in Consolidated Revenue for the Nine Months Ended September 30, 2024, Representing a 136% Increase Over 2023 Results
Phillip Frost Buys Handful Of Shares In OPKO Health
Results: OPKO Health, Inc. Confounded Analyst Expectations With A Surprise Profit
Opko Health Insider Bought Shares Worth $421,535, According to a Recent SEC Filing
OPKO Health Analyst Ratings
Entera Bio Reports Q3 2024 Financial Results and Provides Business Updates
Barrington Maintains Opko Health(OPK.US) With Buy Rating, Maintains Target Price $2.25
OPKO Health: Strategic Maneuvers and Future Profitability Drive Buy Rating
H.C. Wainwright Maintains Opko Health(OPK.US) With Buy Rating, Maintains Target Price $3
OPKO Health, Inc. (OPK) Q3 2024 Earnings Conference Call Transcript
Here's What Key Metrics Tell Us About OPKO Health (OPK) Q3 Earnings
OPKO Health: Q3 Earnings Snapshot
Opko Health | 10-Q: Q3 2024 Earnings Report
Opko Health | 8-K: OPKO Health Reports Third Quarter 2024 Business Highlights and Financial Results